Cytochrome P-450 CYP2C9 Inhibitors (weak)

All categories
DBCAT003038Pharmacologic class

A DrugBank category of 25 drugs. 21 of them are approved.

Part of
Cytochrome P-450 CYP2C9 Inhibitors
Also known as
CYP2C9 Inhibitors (weak) · Weak CYP2C9 Inhibitors
Drugs

What you can answer from here — as of May 20, 2021

25DrugsEach linked to its full drug card
Listed above
109Drug targetsEvery drug–target pair in the class, with bond type
Sign in
10,750Marketed productsAcross the regions we cover, with dosage forms and routes
Sign in
8Routes of administrationHow the drugs in this class are given
Sign in

Which targets do Cytochrome P-450 CYP2C9 Inhibitors (weak) share, and which companies have late-stage candidates in this class?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In